Spectral AI Announces Q3 2024 Financial Results Conference Call
2 Sources
2 Sources
[1]
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call By Investing.com
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (Spectral AI or the Company), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results. Investors interested in participating in the live call can dial: A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company's website at https://investors.spectral-ai.com/news-events/events About Spectral AI Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by Seeing the Unknown ® with its DeepView ® System. DeepView is a predictive device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView, visit www.spectral-ai.com. Forward-Looking Statements Certain statements made in this release are forward looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company's strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words estimates, projected, expects, anticipates, forecasts, plans, intends, believes, seeks, may, will, should, future, propose and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements. Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the Risk Factors sections of the Company's filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
[2]
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call - Spectral AI (NASDAQ:MDAIW), Spectral AI (NASDAQ:MDAI)
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. MDAI ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company's website at https://investors.spectral-ai.com/news-events/events About Spectral AI Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by "Seeing the Unknown®" with its DeepView® System. DeepView is a predictive device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView, visit www.spectral-ai.com. Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company's strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements. Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" sections of the Company's filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Investors: The Equity Group Devin Sullivan Managing Director [email protected] Conor Rodriguez Analyst [email protected] Market News and Data brought to you by Benzinga APIs
Share
Share
Copy Link
Spectral AI, an AI company focused on medical diagnostics in wound care, has scheduled its 2024 third quarter financial results and conference call for November 6, 2024.
Spectral AI Schedules Q3 2024 Financial Results Call
Spectral AI, Inc. (Nasdaq: MDAI), a Dallas-based artificial intelligence company specializing in medical diagnostics for wound care, has announced the date for its 2024 third quarter financial results release and conference call. The company will disclose its financial performance for the quarter ending September 30, 2024, on Wednesday, November 6, 2024, after the stock market closes
1
2
.Conference Call Details
Following the release of the financial results, Spectral AI will host a conference call at 5:00 pm Eastern Time on the same day. Investors interested in participating in the live call can dial:
- 833-630-1956 (U.S.)
- 412-317-1837 (International)
For those unable to join the live call, a simultaneous webcast will be accessible from the Events & Presentations section of the company's Investor Relations page at https://investors.spectral-ai.com/news-events/events
1
2
.About Spectral AI and Its Technology
Spectral AI is focused on revolutionizing wound care management through its innovative DeepView® System. This predictive device utilizes AI to provide clinicians with an objective and immediate assessment of a wound's healing potential prior to treatment or medical intervention
1
2
.The DeepView® System aims to:
- Offer algorithm-driven results
- Exceed the current standard of care
- Provide faster and more accurate treatment insights
- Improve patient outcomes
- Reduce healthcare costs
The company's initial applications involve patients with burns and diabetic foot ulcers, addressing critical areas in medical care where rapid and accurate diagnosis can significantly impact treatment efficacy
1
2
.Related Stories
Forward-Looking Statements and Investor Caution
As with many companies in the AI and medical technology sector, Spectral AI's announcements come with forward-looking statements. These statements are subject to various risks and uncertainties that could cause actual results to differ from projections
1
2
.Investors are advised to carefully consider the risk factors described in the company's SEC filings, including the Registration Statement and other documents. The company emphasizes that these forward-looking statements are not guarantees of future performance and urges readers not to place undue reliance on them
1
2
.Investor Relations Contact
For those seeking more information, Spectral AI has provided contact details for their investor relations team:
- Devin Sullivan, Managing Director at The Equity Group ([email protected])
- Conor Rodriguez, Analyst at The Equity Group ([email protected])
2
As Spectral AI prepares to share its Q3 2024 results, the announcement highlights the growing intersection of AI technology and healthcare, particularly in the field of wound care diagnostics and treatment planning.
References
Summarized by
Navi
[1]
Related Stories
Weekly Highlights
Weekly Highlights
Today's Top Stories
Your Daily Dose of Curated AI News
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.
